SCOOP: Cresco Labs faces arbitration amid Col. Care merger push
Public domain
As MSO Cresco Labs pushes to close its $2B acquisition of rival Columbia Care, it has been embroiled in an arbitration related to another deal. The claims stem from Cresco's acquisition of California operator Origin House, which closed in January 2020.
Initially, Chicago-based Cresco touted the Origin House deal as a fast track . . .
Log in or become a WeedWeek Member to read this article.
